Vascular Solutions Not-Guilty Verdict Another Challenge To FDA Off-Label Oversight
This article was originally published in The Gray Sheet
The case against the venous device manufacturer turned on the rights of manufacturers to use truthful off-label speech to promote their products. It joins a growing body of cases in which courts have sanctioned broader off-label speech than has traditionally been allowed by FDA.
Register for our free email digests: